The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1
Open accessAbstract
CD36 is necessary for inhibition of some angiogenic responses by the matricellular glycoprotein thrombospondin-1 and is therefore assumed to be the receptor that mediates its anti-angiogenic activities. Although ligation of CD36 by antibodies, recombinant type 1 repeats of thrombospondin-1, or CD36-binding peptides was sufficient to inhibit nitric oxide (NO)-stimulated responses in both endothelial and vascular smooth muscle cells, picomolar concentrations of native thrombospondin-1 similarly inhibited NO signaling in vascular cells from wild-type and CD36-null mice. Ligation of the thrombospondin-1 receptor CD47 by recombinant C-terminal regions of thrombospondin-1, thrombospondin-1 peptides, or CD47 antibodies was also sufficient to inhibit NO-stimulated phenotypic responses and cGMP signaling in vascular cells. Thrombospondin-1 did not inhibit NO signaling in CD47-null vascular cells or NO-stimulated vascular outgrowth from CD47-null muscle explants in three-dimensional cultures. Furthermore, the CD36-binding domain of thrombospondin-1 and anti-angiogenic peptides derived from this domain failed to inhibit NO signaling in CD47-null cells. Therefore, ligation of either CD36 or CD47 is sufficient to inhibit NO-stimulated vascular cell responses and cGMP signaling, but only CD47 is necessary for this activity of thrombospondin-1 at physiological concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Papapetropoulos, A., García-Cardeña, G., Madri, J. A., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119868 · Cited by 1,191
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/71517 · Cited by 1,020
Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.-O., Buerk, D. G., Huang, P. L., & Jain, R. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041359198 · Cited by 1,020
Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini, S., Granger, H. J., & Bicknell, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119451 · Cited by 915
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Frazier, W. A., & Bouck, N. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.707 · Cited by 676
Self-citationDecreased Resistance to Bacterial Infection and Granulocyte Defects in IAP-Deficient Mice
Lindberg, F. P., Bullard, D. C., Caver, T. E., Gresham, H. D., Beaudet, A. L., & Brown, E. J. (1996) · Science · doi:10.1126/science.274.5288.795 · Cited by 607
A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation
Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., & Landreth, G. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02665.2003 · Cited by 501
Lawler, J., Sunday, M., Thibert, V, Duquette, M., George, E. L., Rayburn, H., & Hynes, R. O. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1684 · Cited by 457
Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy
Bocci, G., Francia, G., Man, S., Lawler, J., & Kerbel, R. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135406100 · Cited by 414
Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin
Gao, A.-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., & Frazier, W. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.21 · Cited by 402
Self-citationDimmeler, S., Dernbach, E., & Zeiher, A. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01657-4 · Cited by 364
A CD36-initiated Signaling Cascade Mediates Inflammatory Effects of β-Amyloid
Moore, K. J., El Khoury, J., Medeiros, L. A., Terada, K., Geula, C., Luster, A. D., & Freeman, M. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208788200 · Cited by 327
Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1
Ridnour, L. A., Isenberg, J. S., Espey, M. G., Thomas, D. D., Roberts, D. D., & Wink, D. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502979102 · Cited by 323
Self-citationIruela-Arispe, M. L., Lombardo, M., Krutzsch, H. C., Lawler, J., & Roberts, D. D. (1999) · Circulation · doi:10.1161/01.cir.100.13.1423 · Cited by 308
Self-citationAgah, A., Kyriakides, T. R., Lawler, J., & Bornstein, P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64243-5 · Cited by 300
Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner
Isenberg, J. S., Ridnour, L. A., Perruccio, E. M., Espey, M. G., Wink, D. A., & Roberts, D. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502977102 · Cited by 273
Self-citationCooke, J. P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00034-5 · Cited by 266
Crystal structure of the TSP-1 type 1 repeats
Tan, K., Duquette, M., Liu, J.-H., Dong, Y., Zhang, R., Joachimiak, A., Lawler, J., & Wang, J.-H. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200206062 · Cited by 258
Isolation of vascular smooth muscle cells from a single murine aorta
Lynn Ray, J., Leach, R., Herbert, J.-M., & Benson, M. (2001) · Methods in Cell Science · doi:10.1023/a:1016357510143 · Cited by 234
Thrombospondin modulates alpha v beta 3 function through integrin-associated protein.
Gao, A. G., Lindberg, F. P., Dimitry, J. M., Brown, E. J., & Frazier, W. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.2.533 · Cited by 223
Self-citationTumor progression: the effects of thrombospondin-1 and -2
Lawler, J., & Detmar, M. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.008 · Cited by 210
Shizukuda, Y., Tang, S., Yokota, R., & Ware, J. A. (1999) · Circulation Research · doi:10.1161/01.res.85.3.247 · Cited by 174
Chandrasekaran, L. K., He, C.-Z., Al-Barazi, H., Krutzsch, H. C., Iruela‐Arispe, M. L., & Roberts, D. D. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.9.2885 · Cited by 172
Self-citationFrazier, W. A., Gao, A.-G., Dimitry, J., Chung, J., Brown, E. J., Lindberg, F. P., & Linder, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8554 · Cited by 167
Self-citationStructure of a thrombospondin C‐terminal fragment reveals a novel calcium core in the type 3 repeats
Kvansakul, M., Adams, J. C., & Hohenester, E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600166 · Cited by 166
Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior
Li, Z., Calzada, M. J., Sipes, J. M., Cashel, J. A., Krutzsch, H. C., Annis, D. S., Mosher, D. F., & Roberts, D. D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109098 · Cited by 157
Self-citationVogel, T., Guo, N., Krutzsch, H. C., Blake, D. A., Hartman, J. R., Mendelovitz, S., Panet, A., & Roberts, D. D. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530109 · Cited by 153
Self-citationDawson, D. W., Volpert, O. V., Pearce, S. F. A., Schneider, A. J., Silverstein, R. L., Henkin, J., & Bouck, N. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.2.332 · Cited by 141
Short, S. M., Derrien, A., Narsimhan, R. P., Lawler, J., Ingber, D. E., & Zetter, B. R. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407060 · Cited by 137
Wang, S., Wu, Z., Sorenson, C. M., Lawler, J., & Sheibani, N. (2003) · Developmental Dynamics · doi:10.1002/dvdy.10412 · Cited by 133
Namkoong, S., Lee, S., Kim, C., Kim, Y.-M., Chung, H., Lee, H., Han, J.-A., Ha, K., Kwon, Y., & Kim, Y. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.72 · Cited by 124
Zeng, Y., Tao, N., Chung, K.-N., Heuser, J. E., & Lublin, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307722200 · Cited by 122
Wang, X., Lindberg, F. P., & Frazier, W. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.389 · Cited by 117
Self-citationThrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice
Lawler, J., Miao, W., Duquette, M. A., Bouck, N., Bronson, R. T., & Hynes, R. O. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63042-8 · Cited by 117
Thrombospondin-1 Inhibits TCR-Mediated T Lymphocyte Early Activation
Li, Z., He, L., Wilson, K., & Roberts, D. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2427 · Cited by 116
Self-citationCalzada, M. J., Zhou, L., Sipes, J. M., Zhang, J., Krutzsch, H. C., Iruela‐Arispe, M. L., Annis, D. S., Mosher, D. F., & Roberts, D. D. (2003) · Circulation Research · doi:10.1161/01.res.0000115555.05668.93 · Cited by 116
Self-citationChen, D., Asahara, T., Krasinski, K. L., Witzenbichler, B., Yang, J., Magner, M., Kearney, M., Frazier, W. A., Isner, J. M., & Andrés, V. (1999) · Circulation · doi:10.1161/01.cir.100.8.849 · Cited by 103
Self-citationImmunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries
Rießen, R., Kearney, M., Lawler, J., & Isner, J. M. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70105-x · Cited by 101
Calzada, M. J., Annis, D. S., Zeng, B., Marcinkiewicz, C., Banas, B., Lawler, J., Mosher, D. F., & Roberts, D. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406267200 · Cited by 96
Self-citationRegulation of Integrin Function by CD47 Ligands
Barazi, H., Li, Z., Cashel, J. A., Krutzsch, H. C., Annis, D. S., Mosher, D. F., & Roberts, D. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206849200 · Cited by 93
Self-citationYano, K., Kajiya, K., Ishiwata, M., Hong, Y., Miyakawa, T., & Detmar, M. J. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22101.x · Cited by 88
Structure of the calcium-rich signature domain of human thrombospondin-2
Carlson, C. B., Bernstein, D. A., Annis, D. S., Misenheimer, T. M., Hannah, B.-L. A., Mosher, D. F., & Keck, J. L. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb997 · Cited by 86
The N-terminus of thrombospondin: the domain stands apart
Elzie, C. A., & Murphy-Ullrich, J. E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.12.012 · Cited by 79
Bonnefoy, A., Hantgan, R. R., Legrand, C., & Frojmovic, M. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010091200 · Cited by 74
Role of Thrombospondin-1-Derived Peptide, 4N1K, in FGF-2-Induced Angiogenesis
Kanda, S. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4622 · Cited by 72
Lysosomal Integral Membrane Protein II Binds Thrombospondin-1
Crombie, R., & Silverstein, R. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4855 · Cited by 67
Wilson, K., Li, Z., Kara, M., et al. (1999) · PubMed · Cited by 59
Isenberg, J. S., Calzada, M. J., Zhou, L., Guo, N.-H., Lawler, J., Wang, X.-Q., Frazier, W. A., & Roberts, D. D. (2005) · Matrix Biology · doi:10.1016/j.matbio.2005.01.002 · Cited by 57
Self-citationWilson, K. E., Li, Z., Kara, M., Gardner, K. L., & Roberts, D. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3621 · Cited by 53
Self-citationPurification of thrombospondin from human platelets
Roberts, D. D., Cashel, J., & Guo, N.-H. (1994) · Methods in Cell Science · doi:10.1007/bf01540654 · Cited by 46
Self-citationCoronary artery disease and the thrombospondin single nucleotide polymorphisms
Stenina‐Adognravi, O., Byzova, T. V., Adams, J. C., McCarthy, J. J., Topol, E. J., & Plow, E. F. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.005 · Cited by 46
Cholesterol-independent Interactions with CD47 Enhance αvβ3 Avidity
McDonald, J. F., Zheleznyak, A., & Frazier, W. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312782200 · Cited by 44
Self-citationTsao, P. W., & Mousa, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23747 · Cited by 43
Misenheimer, T. M., Huwiler, K. G., Annis, D. S., & Mosher, D. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007022200 · Cited by 43
McDonald, J. F., Dimitry, J. M., & Frazier, W. A. (2003) · Biochemistry · doi:10.1021/bi0341408 · Cited by 35
Self-citationMagnetto, S., Bruno-Bossio, G., Voland, C., Lecerf, J. M., Lawler, J., Delmas, P. D., Silverstein, R. L., & Clézardin, P. (1998) · Cell Biochemistry and Function · Cited by 19
Cited by
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Kojima, Y., Volkmer, J.-P., McKenna, K., Civelek, M., Lusis, A. J., Miller, C. L., Direnzo, D., Nanda, V., Ye, J., Connolly, A. J., et al. (2016) · Nature · doi:10.1038/nature18935 · Cited by 683
Angiogenesis in bone regeneration
Hankenson, K. D., Dishowitz, M., Gray, C., & Schenker, M. (2011) · Injury · doi:10.1016/j.injury.2011.03.035 · Cited by 560
The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer
Matlung, H. L., Szilagyi, K., Barclay, N. A., & van den Berg, T. K. (2017) · Immunological Reviews · doi:10.1111/imr.12527 · Cited by 557
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
Lawler, P. R., & Lawler, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006627 · Cited by 532
Adams, J. C., & Lawler, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009712 · Cited by 457
Metadata
- Authors
- Isenberg, J. S., Ridnour, L. A., Dimitry, J., Frazier, W. A., Wink, D. A., & Roberts, D. D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 281
- Issue
- 36
- Pages
- 26069-26080
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2042436980
- Cited by
- 289
- References
- 56
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.